Maor Lahav - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Maor Lahav

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2026

A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic CancerBrinda Alagesan, Anna M Varghese, Celina Ang, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013

Mutant KRAS is a druggable target for pancreatic cancerElina Zorde Khvalevsky, Racheli Gabai, Itzhak Haim Rachmut, et al.

Gastrointestinal Endoscopy|February 14, 2016

EUS Needle Identification Comparison and Evaluation study (with videos)Shou-Jiang Tang, Andreas S Vilmann, Adrian Saftoiu, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2026

A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic CancerBrinda Alagesan, Anna M Varghese, Celina Ang, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013

Mutant KRAS is a druggable target for pancreatic cancerElina Zorde Khvalevsky, Racheli Gabai, Itzhak Haim Rachmut, et al.

Gastrointestinal Endoscopy|February 14, 2016

EUS Needle Identification Comparison and Evaluation study (with videos)Shou-Jiang Tang, Andreas S Vilmann, Adrian Saftoiu, et al.

Pageof 2